The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in patients with B-cell precursor acute lymphoblastic leukemia receiving inotuzumab ozogamicin stratified by body mass index.
 
Wendy Stock
Honoraria - Newave Pharmaceutical; servier
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Kura Oncology; Newave Pharmaceutical; Pfizer; SERVIER
Research Funding - Kura Oncology
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Ryan Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Autolus; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene
 
Daniel DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Anjali Advani
Consulting or Advisory Role - Amgen; Beam Therapeutics; Beam Therapeutics; Glycomimetics; Jazz Pharmaceuticals; Kite, a Gilead company; Kura Oncology; Nkarta; Novartis; Pfizer; Seagen; SERVIER; Taiho Oncology
Research Funding - Amgen (Inst); Beam Therapeutics (Inst); Glycomimetics (Inst); Immunogen (Inst); Incyte (Inst); Kite/Gilead (Inst); Macrogenics (Inst); OBI Pharma (Inst); Pfizer (Inst); Pfizer (Inst); Seagen (Inst); SERVIER (Inst)
 
Nicola Gökbuget
Honoraria - Amgen; Autolus; Clinigen Group; Incyte; Jazz Pharmaceuticals; Kite/Gilead; Pfizer; SERVIER
Research Funding - Amgen; Clinigen Group; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
 
Jose-Maria Ribera-Santasusana
Consulting or Advisory Role - Amgen; Incyte; Kite/Gilead; Novartis; Pfizer; SERVIER; Takeda
Research Funding - Amgen; Incyte; Pfizer; Takeda
 
Wei Jiang
Employment - Pfizer
 
Susana Pulido
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Erik Vandendries
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma; Autolus; Bristol-Myers Squibb; Genentech; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; TargetRX; Terns Pharmaceuticals
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma Group; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Terns Pharmaceuticals; TGRX
Travel, Accommodations, Expenses - Aptitude Health; Autolus; Daiichi Sankyo Nordics; HMP Education; MD Education; Nucleus Global; ONVIV; Pfizer
 
Hagop Kantarjian
Honoraria - Abbvie; Amgen; Ascentage Pharma Group; Daiichih-Sankyo (Inst); Immunogen (Inst); Ipsen; KAHR Medical; Novartis; Pfizer; Shenzhen Target Rx
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst)